ID   SCC15/R4
AC   CVCL_B5MS
DR   Wikidata; Q112044518
RX   PubMed=6201865;
CC   Population: Caucasian.
CC   Doubling time: 1.5-1.7 days (PubMed=6201865).
CC   Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1681 ! SCC-15
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=6201865; DOI=10.1073/pnas.81.9.2873;
RA   Frei E. III, Rosowsky A., Wright J.E., Cucchi C.A., Lippke J.A.,
RA   Ervin T.J., Jolivet J., Haseltine W.A.;
RT   "Development of methotrexate resistance in a human squamous cell
RT   carcinoma of the head and neck in culture.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:2873-2877(1984).
//